rs758900656
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PM2PP3PP5
The NM_000492.4(CFTR):c.1394C>A(p.Thr465Asn) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00000188 in 1,596,306 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000492.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFTR | NM_000492.4 | c.1394C>A | p.Thr465Asn | missense_variant, splice_region_variant | Exon 11 of 27 | ENST00000003084.11 | NP_000483.3 | |
CFTR-AS1 | NR_149084.1 | n.221+1268G>T | intron_variant | Intron 2 of 2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152134Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251196Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135770
GnomAD4 exome AF: 0.00000138 AC: 2AN: 1444172Hom.: 0 Cov.: 27 AF XY: 0.00000139 AC XY: 1AN XY: 719796
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152134Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74302
ClinVar
Submissions by phenotype
Cystic fibrosis Pathogenic:2Uncertain:1
- -
Identified in combination with F508del in two affected siblings -
Variant summary: CFTR c.1394C>A (p.Thr465Asn) results in a non-conservative amino acid change located in the ABC transporter-like domain and ATPase domain (IPR003439) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251196 control chromosomes (gnomAD). c.1394C>A has been reported in the literature in individuals affected with Cystic Fibrosis (example, Kammesheidt_2006, Lucarelli_2015, Bozdogan_2021, Raraigh_2022) as well as at least one CBAVD patient (example, Yuan_2019). One internal sample and their affected sibling also tested positive for this variant with deltaF508 in trans. These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect resulted in approximately (Gt channel conductance) 0.86% of normal chloride channel conductance relative to wild type (e.g., Bihler_2024). The following publications have been ascertained in the context of this evaluation (PMID: 33572515, 35913788, 16980811, 25910067, 22504961, 34782259, 30811104, 38388235). ClinVar contains an entry for this variant (Variation ID: 495896). Based on the evidence outlined above, the variant was classified as pathogenic. -
not provided Pathogenic:1Uncertain:1
The CFTR c.1394C>A (p.Thr465Asn) variant has been reported in the published literature in individuals affected with cystic fibrosis (PMIDs: 34782259 (2021), 25910067 (2015), 16980811 (2006)) and CFTR-related disease including congenital absence of the vas deferens (PMIDs: 35913788 (2022), 30811104 (2019)). The frequency of this variant in the general population, 0.000004 (1/251196 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded predictions that this variant is damaging. Based on the available information, this variant is classified as likely pathogenic. -
- -
Cystic fibrosis;C0403814:Congenital bilateral aplasia of vas deferens from CFTR mutation Pathogenic:1
- -
Bronchiectasis with or without elevated sweat chloride 1 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at